Birdwatch Note
2023-07-09 15:04:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
コロナへのイベルメクチン、最大用量でも効果認められず／JAMA Carenet医療ニュース https://www.carenet.com/news/journal/carenet/56059 「イベルメクチン」の誤用による「薬剤耐性疥癬」増加の可能性（2023/3/12） |Thailand Medical News https://www.thailandmedical.news/news/breaking-extensive-ivermectin-misuse-during-the-covid-19-pandemic-is-possibly-leading-to-rising-cases-of-drug-resistant-scabies
Written by 8C120F8B617DBAC9E4696DE6F24E78952C3CAB0AAA8B11A719AE451FCC3B40DD
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1677889568371245056
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1678057635114008579
- noteId - 1678057635114008579
- participantId -
- noteAuthorParticipantId - 8C120F8B617DBAC9E4696DE6F24E78952C3CAB0AAA8B11A719AE451FCC3B40DD Participant Details
- createdAtMillis - 1688915091672
- tweetId - 1677889568371245056
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- コロナへのイベルメクチン、最大用量でも効果認められず／JAMA Carenet医療ニュース https://www.carenet.com/news/journal/carenet/56059 「イベルメクチン」の誤用による「薬剤耐性疥癬」増加の可能性（2023/3/12） |Thailand Medical News https://www.thailandmedical.news/news/breaking-extensive-ivermectin-misuse-during-the-covid-19-pandemic-is-possibly-leading-to-rising-cases-of-drug-resistant-scabies
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-07-09 15:04:51 UTC (1688915091672) |
1969-12-31 23:59:59 UTC (-1) |
2023-07-10 05:43:02 UTC (1688967782468) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-07-09 16:15:38 -0500 | Rating Details | |
| 2023-07-09 14:53:44 -0500 | Rating Details | |
| 2023-07-09 13:35:30 -0500 | Rating Details | |
| 2023-07-09 12:00:28 -0500 | Rating Details | |
| 2023-07-09 11:27:38 -0500 | Rating Details | |
| 2023-07-09 10:56:35 -0500 | Rating Details | |
| 2023-07-09 10:31:00 -0500 | Rating Details | |
| 2023-07-09 10:30:20 -0500 | Rating Details | |
| 2023-07-09 10:23:43 -0500 | Rating Details | |
| 2023-07-10 06:18:59 -0500 | Rating Details | |
| 2023-07-10 06:06:13 -0500 | Rating Details | |
| 2023-07-10 05:52:41 -0500 | Rating Details | |
| 2023-07-10 05:50:30 -0500 | Rating Details | |
| 2023-07-10 05:37:22 -0500 | Rating Details | |
| 2023-07-10 05:18:25 -0500 | Rating Details | |
| 2023-07-10 05:16:21 -0500 | Rating Details | |
| 2023-07-10 05:07:45 -0500 | Rating Details | |
| 2023-07-10 05:00:03 -0500 | Rating Details | |
| 2023-07-10 04:56:03 -0500 | Rating Details | |
| 2023-07-10 04:52:23 -0500 | Rating Details | |
| 2023-07-10 04:37:09 -0500 | Rating Details | |
| 2023-07-10 04:10:13 -0500 | Rating Details | |
| 2023-07-10 03:52:16 -0500 | Rating Details | |
| 2023-07-10 03:45:41 -0500 | Rating Details | |
| 2023-07-10 03:18:19 -0500 | Rating Details | |
| 2023-07-10 03:16:50 -0500 | Rating Details | |
| 2023-07-10 02:52:59 -0500 | Rating Details | |
| 2023-07-10 02:38:41 -0500 | Rating Details | |
| 2023-07-10 02:38:02 -0500 | Rating Details | |
| 2023-07-10 02:31:50 -0500 | Rating Details | |
| 2023-07-10 02:19:52 -0500 | Rating Details | |
| 2023-07-10 02:04:29 -0500 | Rating Details | |
| 2023-07-10 01:33:54 -0500 | Rating Details | |
| 2023-07-10 01:32:51 -0500 | Rating Details | |
| 2023-07-10 01:32:27 -0500 | Rating Details | |
| 2023-07-10 01:16:00 -0500 | Rating Details | |
| 2023-07-10 01:13:30 -0500 | Rating Details | |
| 2023-07-10 00:50:22 -0500 | Rating Details | |
| 2023-07-10 00:44:58 -0500 | Rating Details | |
| 2023-07-12 06:23:48 -0500 | Rating Details | |
| 2023-07-12 01:18:12 -0500 | Rating Details | |
| 2023-07-11 22:37:00 -0500 | Rating Details | |
| 2023-07-11 17:37:49 -0500 | Rating Details | |
| 2023-07-11 01:11:16 -0500 | Rating Details | |
| 2023-07-09 13:16:04 -0500 | Rating Details | |
| 2023-07-12 02:44:37 -0500 | Rating Details | |
| 2023-07-11 23:18:30 -0500 | Rating Details | |
| 2023-07-16 20:17:59 -0500 | Rating Details | |
| 2023-07-11 07:53:12 -0500 | Rating Details | |
| 2023-07-12 02:24:43 -0500 | Rating Details | |
| 2023-07-11 03:45:36 -0500 | Rating Details | |
| 2023-07-16 19:01:04 -0500 | Rating Details | |
| 2023-07-20 02:13:45 -0500 | Rating Details |